MARKETS

ASLAN Pharmaceuticals faces Nasdaq delisting over equity deficit

Kgaogelo MatshwiKgaogelo Matshwi
Apr 19, 2024 - 23:17
 0  5
ASLAN Pharmaceuticals faces Nasdaq delisting over equity deficit
Read More

Tags:

Previous Article

Creditors and Ghana Eye Restructuring Deal by End of May

Next Article

GFG Closes Private Placement Financing

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Kgaogelo Matshwi
Kgaogelo Matshwi

Related Posts

Altman-Backed SPAC That’s Targeting Nuclear Firm Has Surged 22%

Altman-Backed SPAC That’s Targeting Nuclear Firm Has Su...

Kgaogelo Matshwi Apr 4, 2024  0  12

More frequent and extreme weather events pose increasing risks to employee health and business performance

More frequent and extreme weather events pose increasin...

Kgaogelo Matshwi Apr 22, 2024  0  5

$510M longs at risk if Ether repeats last weekend’s volatility

$510M longs at risk if Ether repeats last weekend’s vol...

Kgaogelo Matshwi Apr 26, 2024  0  2